Elanco Animal Health Incorporated

ELAN · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders1.2%

Institutions115.4%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$4.71B	$4.44B	$4.42B	$4.41B	$4.76B	$3.27B	$3.07B	$3.07B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$2.12B	$2.00B	$1.93B	$1.91B	$2.13B	$1.67B	$1.47B	$1.57B
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$2.59B	–	–	–	–	–	–	–
Gross profit as a percentage of revenue.	55.0%	–	–	–	–	–	–	–
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$232.00M	$338.00M	-$1.23B	-$78.00M	-$472.00M	-$560.10M	$67.90M	$86.50M
Net income divided by the number of shares outstanding — profit attributable to each share.	$0.00	$0.00	$-2.00	$-0.16	$-0.97	$-1.27	$0.00	$0.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$0.00	$0.00	$-2.00	$-0.16	$-0.97	$-1.27	$0.00	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$545.00M	$468.00M	$352.00M	$345.00M	$638.00M	$494.70M	$334.00M	$474.80M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$13.36B	$12.61B	$14.36B	$15.49B	$16.48B	$17.69B	$8.99B	$8.96B
All of the company's interest-bearing borrowings, short and long term combined.	–	$4.32B	$5.77B	$5.84B	$6.32B	$6.13B	$2.35B	$2.47B
Everything the company owes — debt, unpaid bills, and other obligations.	$6.81B	$6.52B	$8.14B	$8.20B	$8.95B	$9.22B	$3.44B	$3.76B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$6.55B	$6.10B	$6.22B	$7.29B	$7.54B	$8.48B	$5.55B	$5.20B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$560.00M	$541.00M	$271.00M	$452.00M	$483.00M	-$41.00M	$224.10M	$487.30M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$276.00M	$147.00M	$140.00M	$137.00M	$126.00M	$134.60M	$140.40M	$134.50M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$284.00M	$394.00M	$131.00M	$315.00M	$357.00M	-$175.60M	$83.70M	$352.80M

	You	Peer avg
P/E	–	20.5
Revenue Growth	+10.2%	+6.7%
ROE	-3.0%	30.7%

Elanco Animal Health Incorporated

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison